ReviewInternational journal of cardiology. Heart & vasculature2024
Risk of atrial fibrillation in patients with inflammatory bowel disease: A systematic review and meta-analysis.
Review in International journal of cardiology. Heart & vasculature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent highlights from theInternational journal of cardiology. Heart & vasculature · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Several studies have reported the association between inflammatory bowel disease (IBD) and the risk of atrial fibrillation (AF). This systematic review and Methods: We conducted a systematic search of the PubMed and Embase databases for relevant studies published up to February 2024. We used the random-effects model to pool the prevalence and incidence rates of AF among IBD patients. The subgroup analyses were performed according to the IBD type. Results: A total of twenty-five studies were included. The pooled prevalence of AF among IBD patients was 6.23 % (95 % confidence interval [CI]: 4.99 %-7.47 %). The incidence rate of AF among IBD patients was 3.53 % (95 % CI: 0.57 %-6.48 %). The risk of developing AF in IBD patients was 1.45 times higher than that in the general population (risk ratio [RR]: 1.45, 95 % CI: 1.21-1.73). When comparing specific IBD types to the general population, the RR was 1.35 (95 % CI: 1.11-1.64) for CD and 1.17 (95 % CI: 1.11-1.23) for UC. Conclusions: Our findings suggest that IBD patients exhibit an increased risk of developing AF compared to the general population. CD patients have a higher AF incidence compared to UC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.